Conciseness

Largely lean, table-driven content with no explanations of concepts Claude already knows, but there is trimmable redundancy: '(requires NVIDIA_API_KEY env var; free key at build.nvidia.com)' is repeated in every relevant row of two tables and then again in a dedicated 'NVIDIA NIM Requirements' section, and the 'Common Parameter Mistakes' table partially restates the key parameters from the tool table. This fits the level-4 anchor (efficient with minor over-explanation) rather than 5, where every token earns its place.

Actionability

Gives executable specifics: exact tool names, the correct parameter for each ('diffusion_steps (NOT num_steps)', 'pdb_string (NOT pdb)'), rate limits ('40 RPM'), thresholds, and minimum counts ('>= 5 backbones', '>= 8 sequences per backbone'). Not a 5 because the body contains no actual runnable call/code examples — those are deferred to reference files — and 'write and run Python code via Bash' is direction rather than instruction.

Workflow Clarity

The six-phase workflow is clearly sequenced with an explicit validation phase ('Predict structure, compare to backbone, assess pLDDT/pTM'), tiered acceptance criteria (T1–T4), and a completeness checklist with pass gates ('>= 3 passing'). Not a 5 because error-recovery/fallback loops are only promised in the (missing) DESIGN_PROCEDURES.md rather than stated, and per-phase execution detail is entirely external.

Progressive Disclosure

The body ends with a clearly signaled, well-annotated one-level-deep reference list (five files with one-line descriptions), which is the right structure. However, none of the referenced files (DESIGN_PROCEDURES.md, TOOLS_REFERENCE.md, EXAMPLES.md, CHECKLIST.md, design_templates.md) exist in the bundle — there is no references/ directory at all — so the disclosure structure is asserted but not actually realized, leaving navigation broken.

Specificity

Names three concrete, tool-anchored actions — 'RFdiffusion backbone generation, ProteinMPNN sequence design, structure validation (pLDDT, pTM, MPNN scores)' — with specific metrics. Not a 5 because the workflow the skill actually covers includes target characterization and developability assessment, which the description omits (minor coverage gaps fitting the level-4 anchor).

Completeness

Explicitly answers both questions: what it does ('RFdiffusion backbone generation, ProteinMPNN sequence design, structure validation') and when to use it ('Use for designing therapeutic protein binders, novel scaffolds, enzyme variants, and miniprotein/protein-interface design before experimental validation'), matching the level-5 anchor with concrete trigger phrases.

Trigger Term Quality

Includes natural phrases users would say — 'de novo protein design', 'therapeutic protein binders', 'novel scaffolds', 'enzyme variants', 'protein-interface design'. Not a 5 because common synonyms and phrasings users actually use (antibody/nanobody design, binder design, protein engineering) are absent.

Distinctiveness Conflict Risk

A clear niche (AI-guided de novo therapeutic protein design) with distinct tool and domain triggers (RFdiffusion, ProteinMPNN, pLDDT, pTM) that virtually no other skill would share, matching the level-5 'clear niche with distinct triggers' anchor. Voice is third-person throughout, so no specificity penalty applies.